Standard Anti-Cancer Diet

BEHAVIORAL2 trials

Sponsors

Cedars-Sinai Medical Center, Stephen Freedland

Conditions

Glioblastoma MultiformeProstate Adenocarcinoma

Phase 2

A Phase 2 Study of the Ketogenic Diet vs Standard Anti-cancer Diet Guidance for Patients With Glioblastoma in Combination With Standard-of-care Treatment

RecruitingNCT05708352

Cedars-Sinai Medical CenterGlioblastoma Multiforme

Start: 2023-06-27End: 2029-09-30Target: 170Updated: 2025-12-24

Intermittent Fasting Using a Fasting-Mimicking Diet to Improve Prostate Cancer Control and Metabolic Outcomes

RecruitingNCT05832086

Stephen FreedlandProstate Adenocarcinoma

Start: 2023-09-13End: 2029-03-30Target: 138Updated: 2025-10-06

Related Papers

CTNI-64. TRIAL IN PROGRESS: DIET2TREAT -- A RANDOMIZED MULTICENTER PHASE 2 TRIAL OF A KETOGENIC DIET VS STANDARD DIETARY GUIDANCE IN COMBINATION WITH STANDARD-OF-CARE TREATMENT FOR PATIENTS WITH NEWLY DIAGNOSED GLIOBLASTOMA

Neuro-Oncology2024-11-01

DIET2TREAT: A randomized, multi-center, phase 2 trial of a ketogenic diet vs standard dietary guidance in combination with standard-of-care treatment for patients with newly diagnosed glioblastoma.

Journal of Clinical Oncology2024-06-01